BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180129
DTEND;VALUE=DATE:20180202
DTSTAMP:20260515T083523
CREATED:20170919T071927Z
LAST-MODIFIED:20170919T073104Z
UID:3147-1517184000-1517529599@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics 2018
DESCRIPTION:In planning the 2018 Temperature Controlled Logistics conference\, Pharma IQ surveyed over 50 senior supply chain and logistics experts from big and small pharmaceutical companies\, as well as from consumer industries. The main question they were looking to answer was: what is the main factor that defines a cost effective\, secure\, and GDP compliant temperature controlled supply chain that experiences minimal temperature excursions? The overarching answer was clear: planning. Strengthen your end-to-end supply chain planning\, and your temperature controlled logistics will be easier\, cheaper\, and better. \n  \nIn recognition of this\, TCL 2018\, takes you on a journey from the beginning of your supply chain\, to the very end. The three separate streams will look at: \n-> Pre-Transportation – with sessions such as “Enabling End-to-End Supply Chain Planning\, Visibility\, and Decision Making through Standardisation & IT Integration Across Global Sites” (Merck) and “Optimising Lane Qualification with all Supply Chain Stakeholders in Challenging Shipping Environments” (Bayer) \n-> Transportation – with sessions such as “A Global Approach to Reducing Temperature Excursions” (Genzyme) and “Maintaining Temperature Control in the World’s Most Challenging Situations” (Médecins Sans Frontières) \n-> Last Mile and Post-Distribution – with sessions such as “Last Mile Distribution – The Final Stage of End-to-End Temperature Monitoring (EZR Group) and “Working with Partners to Close Gaps in the Last Mile” (Novartis) \nThe goal of the event  is for each and every delegate who attends TCL 2018 to leave understanding what best practice planning and execution looks like at every stage of their temperature controlled supply chain. With over 50 case studies from pharmaceutical manufactures and regulatory bodies that address key operational and strategic considerations\, bring your team to ensure coverage of all relevant sessions. \nThe  world famous exhibition will\, as per tradition\, run parallel to the conference\, so that you have the chance to identify solution providers who can support the implementation of new solutions and strategies. In a brand new location of Twickenham Stadium\, the big red London bus won’t be joining this year\, but they have plenty of new surprises that await!  Don’t to miss the BRAND NEW Sea Freight Focus Day! Details on the agenda at https://www.temperaturecontrolledlogistics.com/ \nThe early bird special has just kicked off\, and there are a few ways to capitalise on these discounts:\n1. Online here: https://www.temperaturecontrolledlogistics.com/\n2. Email: enquire@iqpc.co.uk\n3. Telephone +44 (0) 20 7036 1300
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-2018/
LOCATION:Twickenham Stadium\, London
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180205
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T083523
CREATED:20171121T064101Z
LAST-MODIFIED:20171121T064454Z
UID:4351-1517788800-1518047999@www.pharmajournalist.com
SUMMARY:3rd annual North American Microbiome Congress
DESCRIPTION:The 3rd Annual North America Microbiome Congress in San Diego\, by Kisaco Research\, has become a trusted learning and networking platform and a true business community for microbiologists\, clinicians regulatory and industry executives who require an insight into the latest microbiome research\, clinical trials and collaborative partnerships. \nWith a focus on 5 microbiome niches such as the gut\, lung\, oral\, skin and vaginal- we invite you to join us for 3 days of intense learning\, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition\, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work. \n– Meet and learn from industry leaders\n– Consider the practical aspects of promoting effective partnerships\n– Learn from the latest unpublished data\n– Network with top academics and clinicians in the field
URL:https://www.pharmajournalist.com/event/3rd-annual-north-american-microbiome-congress/
LOCATION:The Hilton San Diego Resort & Spa\, 1775 East Mission Bay Drive\, San Diego\, CA\, 92109\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180206
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T083523
CREATED:20171031T005520Z
LAST-MODIFIED:20171031T005651Z
UID:3633-1517875200-1518047999@www.pharmajournalist.com
SUMMARY:12th annual Parallel Trade
DESCRIPTION:SMi Group is proud to announce the return of Europe’s only Parallel Trade conference. Back for the 12th year\, Parallel Trade returns to London on 6th-7th February 2018. \n \nOver the years\, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers. However\, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019\, the market for pharmaceutical parallel trade is changing. \nJoin us as we discuss the latest changes to regulation\, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Parallel Trade event. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers \nParallel Trade 2018 will cover the important issues of:\n \n– Maintaining the integrity of the supply chain\n– Addressing recent developments concerning intellectual property and regulatory law\n– Forecasting currency fluctuations across the single market and the affect this might have on drug shortages\, prices and patient accessibility\n– Exploring how Brexit will impact pharmaceutical trade and\n– market access in Europe\n– Providing an insight into current anti-trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade
URL:https://www.pharmajournalist.com/event/12th-annual-parallel-trade/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T083523
CREATED:20171011T060348Z
LAST-MODIFIED:20171011T060745Z
UID:3391-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:10th Annual Pharma Packaging and Labeling East Coast Conference
DESCRIPTION:The 10th Annual Pharma Packaging and Labeling East Coast event aims to create an environment where commercial packaging and labeling teams work together to successfully manage both creative and regulatory demands while safeguarding products and protecting patients. To achieve this we have brought together top industry leaders whose experience will enable you to make this a reality. \nThis year we will be exploring topics which affect both commercial labelling and packaging teams across small\, medium and large pharma. We will have a co-presentation looking at the industries end-to-end labeling strategy to ensure companies are inspection ready while harnessing branding as a story telling the tool to remain relevant to your consumers\, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards. We are also happy to announce that the Drug Enforcement Administration will be returning\, offering an opportunity to hear a different perspective on ways that pharma can serve the public health. \nTo learn more about this event\, and to register online\, visit https://goo.gl/3HhKjN
URL:https://www.pharmajournalist.com/event/10th-annual-pharma-packaging-labeling-east-coast-conference/
LOCATION:Philadelphia\, USA\, TBA
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T083523
CREATED:20171023T075622Z
LAST-MODIFIED:20171023T084319Z
UID:3564-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:3D Cell Culture 2018
DESCRIPTION:Building on the sell-out success of the launch event\, SMi Group is delighted to announce the return of 3D Cell Culture\, taking place on 21st and 22nd of February 2018\, in London UK. \n3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields\, such as 3D bioprinting and microfluidics. \nThe 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models\, organoids\, organ-on-a-chip technologies\, iPSC advances plus much more!  \nFEATURED SPEAKERS: \n– Gary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Bioscience\n– Mr Stefan Przyborski\, Scientific Founder\, ReInnervate Limited\n– Mr Ricardo Baptista\, Lead Scientist Process Development\, Cell and Gene Therapy Catapult\n– Dr Nicholas Leslie\, Tumour Biologist\, Heriot-Watt University\n– Dr SuwanJaysinghe\, Professor of Bioengineering\, University College London\n– Dr Max Salick\, Postdoctoral Researcher\, Novartis Institutes for Biomedical Research\n– Dr Patrick Kugelmeier\, Director of Science\, Kugelmeiers\n– Dr Vitor Santo\, Senior Scientist\, Immunocore\n– Mr Christopher Schofield\, Investigator\, GSK\n– Mr David Pan\, Programme Manager (Regenerative Medicine)\, UK Regenerative Medicine Platform\n– Dr Reyk Horland\, Head of Business Development\, TissUse GmbH \nREASONS TO ATTEND IN 2018\n \n– Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing\n– Take a 3D biology approach to overcome challenges for well based screening with exclusive insight into electrospun micro-scaffold based biology\n– Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing\n– Discover new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology\n– Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis \n2017 ATTENDEE TESTIMONIALS \n“Very good presentations and a few outstanding ones… I made some useful contacts” ASTERAND BIOSCIENCE \n“The conference was wonderfully organised” NOVARTIS \n“Good start\, love to see the event occur again” THERMO FISHER SCIENTIFIC \n\nFor further details visit http://www.3D-CellCulture.com/pjournalist or contact the team on +44 (0)20 7827 6000
URL:https://www.pharmajournalist.com/event/3d-cell-culture-2018/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
END:VCALENDAR